TWI337863B - Use of resveratrol for preparation of a medicament useful for the treatment of influenza virus infections - Google Patents

Use of resveratrol for preparation of a medicament useful for the treatment of influenza virus infections Download PDF

Info

Publication number
TWI337863B
TWI337863B TW092129780A TW92129780A TWI337863B TW I337863 B TWI337863 B TW I337863B TW 092129780 A TW092129780 A TW 092129780A TW 92129780 A TW92129780 A TW 92129780A TW I337863 B TWI337863 B TW I337863B
Authority
TW
Taiwan
Prior art keywords
resveratrol
virus
cells
infection
influenza virus
Prior art date
Application number
TW092129780A
Other languages
English (en)
Chinese (zh)
Other versions
TW200501935A (en
Inventor
Enrico Garaci
Anna Teresa Palamara
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of TW200501935A publication Critical patent/TW200501935A/zh
Application granted granted Critical
Publication of TWI337863B publication Critical patent/TWI337863B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW092129780A 2002-11-06 2003-10-27 Use of resveratrol for preparation of a medicament useful for the treatment of influenza virus infections TWI337863B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.

Publications (2)

Publication Number Publication Date
TW200501935A TW200501935A (en) 2005-01-16
TWI337863B true TWI337863B (en) 2011-03-01

Family

ID=32310188

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092129780A TWI337863B (en) 2002-11-06 2003-10-27 Use of resveratrol for preparation of a medicament useful for the treatment of influenza virus infections

Country Status (18)

Country Link
US (1) US8431617B2 (https=)
EP (1) EP1567137B1 (https=)
JP (1) JP4589118B2 (https=)
KR (1) KR101060331B1 (https=)
AR (1) AR041891A1 (https=)
AT (1) ATE381929T1 (https=)
AU (1) AU2003279551A1 (https=)
CA (1) CA2504872C (https=)
CY (1) CY1107302T1 (https=)
DE (1) DE60318327T2 (https=)
DK (1) DK1567137T3 (https=)
ES (1) ES2295660T3 (https=)
IT (1) ITRM20020562A1 (https=)
MX (1) MXPA05004628A (https=)
PL (1) PL217628B1 (https=)
PT (1) PT1567137E (https=)
TW (1) TWI337863B (https=)
WO (1) WO2004041260A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951285A2 (en) * 2005-11-18 2008-08-06 Ares Trading S.A. Interferon in influenza
EP2268272A2 (en) * 2008-03-06 2011-01-05 Mount Sinai School of Medicine of New York University Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
WO2010053949A1 (en) * 2008-11-04 2010-05-14 Metaproteomics, Llc Phytochemical compositions and methods for activating amp-kinase
US20110236349A1 (en) * 2008-12-19 2011-09-29 Koff Jonathan L Use of Epidermal Growth Factor Inhibitors in the Treatment of Viral Infection
KR100950445B1 (ko) 2009-10-26 2010-04-02 주식회사 중앙백신연구소 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
WO2011150413A1 (en) 2010-05-28 2011-12-01 Mount Sinai School Of Medicine Antiviral compounds and uses thereof
CA2850597A1 (en) * 2011-09-30 2013-04-04 Vanderbilt University Antiviral therapies with phospholipase d inhibitors
EP2952209B1 (en) 2014-06-04 2018-03-28 Alfasigma S.p.A. Homogeneous formulations comprising omega-3 polyunsaturated fatty acids (n-3 PUFA) and resveratrol for oral administration
EP2952180B1 (en) 2014-06-04 2017-01-25 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Solid formulations containing resveratrol and omega-3 polyunsaturated fatty acids (n-3 PUFA)
EP3120842A1 (en) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid
KR20170039456A (ko) 2015-10-01 2017-04-11 동아대학교 산학협력단 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) * 2016-08-09 2018-02-15 株式会社ブレインヘルス 抗生物質含有組成物
CN108893558B (zh) * 2018-05-24 2022-04-05 江苏海宏制药有限公司 一种桑木液原液抗病毒实验方法以及装置
EP4132277B1 (en) * 2020-04-05 2025-11-26 Mong, Michael Systems and methods for treating coronavirus
WO2026044308A1 (en) 2024-08-26 2026-03-05 Medizinische Universität Wien Treatment and prevention of diseases caused by influenza virus with 3,3',4,4',5,5'-hexahydroxy-trans-stilbene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778337B1 (fr) 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
PE20010540A1 (es) 1999-07-30 2001-05-15 Procter & Gamble Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
DE60015568D1 (de) * 1999-08-13 2004-12-09 Univ Maryland Biotech Inst Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür

Also Published As

Publication number Publication date
JP2006507295A (ja) 2006-03-02
TW200501935A (en) 2005-01-16
PL217628B1 (pl) 2014-08-29
JP4589118B2 (ja) 2010-12-01
KR20050071627A (ko) 2005-07-07
US20050239906A1 (en) 2005-10-27
CA2504872C (en) 2011-07-05
AR041891A1 (es) 2005-06-01
CY1107302T1 (el) 2012-11-21
AU2003279551A1 (en) 2004-06-07
US8431617B2 (en) 2013-04-30
EP1567137A1 (en) 2005-08-31
ATE381929T1 (de) 2008-01-15
PT1567137E (pt) 2008-02-19
DE60318327T2 (de) 2008-12-18
CA2504872A1 (en) 2004-05-21
ES2295660T3 (es) 2008-04-16
PL377557A1 (pl) 2006-02-06
WO2004041260A1 (en) 2004-05-21
EP1567137B1 (en) 2007-12-26
ITRM20020562A1 (it) 2004-05-07
DE60318327D1 (de) 2008-02-07
MXPA05004628A (es) 2005-09-08
DK1567137T3 (da) 2008-04-28
KR101060331B1 (ko) 2011-08-30

Similar Documents

Publication Publication Date Title
TWI337863B (en) Use of resveratrol for preparation of a medicament useful for the treatment of influenza virus infections
Zhao et al. A broad-spectrum virus-and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2
Leneva et al. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses
EP2471529A2 (en) Kinase Inhibitors for Preventing or Treating Pathogen Infection and Method of Use Thereof
Johnston et al. Myxoma virus infection of primary human fibroblasts varies with cellular age and is regulated by host interferon responses
Ahmed et al. Antiviral activity of Ribavirin nano-particles against measles virus
CA2465062C (en) Preventive and/or therapeutic agent for viral infection
US20230218663A1 (en) Compositions and methods for treating a sars-cov-2 infection
EP4149469A1 (en) Use of compounds for treating viral infections
Saikrupa et al. Rational Use of Methylene Blue in COVID-19 Treatment.
US20230248680A1 (en) Use of rigosertib to treat rna virus infections
CN108014129A (zh) 铁离子在抑制rna病毒中的应用
CN115968287A (zh) 针对冠状病毒感染及其引起疾病的活性剂
CN114762694A (zh) 寡糖转移酶抑制剂在预防和/或治疗新型冠状病毒感染中的应用
WO2022079496A1 (en) A pharmaceutical composition of nitazoxanide, albendazole and pyrantel and method thereof
CZ308937B6 (cs) Použití hem arginátu pro výrobu léčiva pro léčbu infekce beta koronaviry
CN111214472B (zh) 依诺沙星在制备预防和/或治疗黄病毒感染的药物中的应用
ES2586505B1 (es) Análogos de ferruginol como agentes antivirales
Paliwal et al. A COMPREHENSIVE REVIEW ON COVID-19 WITH THEIR TREATMENT APPROACHES
CN116531509A (zh) 一种基于天然萘醌的药物组合物及应用
EP4000614A1 (en) Efloxate for use as antiviral agent
CN114712342A (zh) 紫草酸在制备抗流感病毒药物中的应用
CN121796438A (zh) 六神丸在治疗多种病毒感染所致疾病中的应用
Desloovere MK2206 inhibits influenza A (H1N1) pdm2009 virus infection
HK1067944A (en) Preventives/remedies for viral infection

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent